Please Wait.....
Report
Latin America In-vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Latin America In-vitro Colorectal Cancer Screening Tests Market Report and Forecast 2024-2032
Latin America In-vitro Colorectal Cancer Screening Tests Market Size
The global in-vitro colorectal cancer screening tests market was valued at USD 920.4 million in 2023, with Latin America holding a significant market share. The market is driven by the growing demand for non-invasive or minimally invasive colorectal cancer screening methods. It is expected to grow at a CAGR of 5.53% during the forecast period of 2024-2032, with the values likely to attain USD 1492.8 million by 2032.
Latin America In-vitro Colorectal Cancer Screening Tests Market Outlook
- The market share is influenced by the growing preference for non-invasive colorectal cancer screening methods such as fecal immunochemical tests (FIT) and DNA-based tests.
- In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) jointly launched the Latin American and the Caribbean Code against Cancer to develop recommendations for cancer prevention in the region. Such initiatives are likely to increase screening rates, which is expected to elevate the Latin America in-vitro colorectal cancer screening tests market value in the forecast period.
- In Brazil, colorectal cancer stands as the second most frequent cancer in men and women, with the mortality rate estimated to reach 9.4% of those diagnosed. The rising burden of colorectal cancer is poised to augment the market demand for in-vitro screening tests.
Latin America In-vitro Colorectal Cancer Screening Tests Market Analysis
In-vitro colorectal cancer screening tests are designed to detect abnormalities such as blood in stool, genetic mutations, or other biomarkers associated to colorectal cancer. They can identify individuals at a high risk of colorectal cancer and thus play an integral role in early detection and prevention efforts. The increasing use of these diagnostic tests can be attributed to the non-invasive or minimally invasive nature is expected to fuel their adoption rates and drive the Latin America in-vitro colorectal cancer screening tests market growth.
Recent data suggests that deaths due to colorectal cancer are rising in Latin American countries. In Brazil, colorectal cancer stands as the second most frequent cancer in men and women, with the mortality rate estimated to reach 9.4% of those diagnosed. This indicates the growing need for effective screening tests, intended to detect this cancer at an early stage when the interventions are most likely to be successful. Thus, the rising burden of colorectal cancer coupled with the increasing aging population, is poised to augment the market demand for these diagnostic tests.
One of the major Latin America in-vitro colorectal cancer screening tests market trends is the increased initiatives and awareness campaigns to promote cancer screening and reduce cancer mortality rates. In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) collaborated to launch the Latin American and the Caribbean Code against Cancer to develop recommendations for cancer prevention in the region. They released 17 actions to help prevent cancer including the need for early detection tests of colorectal cancer for people aged between 50 and 74 . Such collaborative measures are likely to increase awareness among the public, leading to higher screening rates and greater adoption of in-vitro screening tests, and ultimately propelling the market growth.
Latin America In-vitro Colorectal Cancer Screening Tests Market Segmentation??
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Testing Type
Fecal Occult Blood Tests
Biomarker Tests
CRC DNA Screening Tests
Flexible Sigmoidoscopy
Others
Market Breakup by Imaging Type
Colonoscopy
Proctoscopy
CT Scan
Ultrasound
MRI
PET Scan
Market Breakup by End User
Hospitals
Clinics
Diagnostics Laboratories
Market Breakup by Country
Brazil
Argentina
Mexico
Others
Leading Players in the Latin America In-vitro Colorectal Cancer Screening Tests Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Beckman Coulter Inc.
- Abbott
- Siemens Healthineers International AG
- Quest Diagnostics
- Oncocyte Corporation
- Merck KGaA
- Randox Laboratories Ltd.
- R-Biopharm AG
- Sysmex Corporation
- Medline Industries LP
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Latin America in-vitro colorectal cancer screening tests market forecast outlook for 2024-2032?
The Latin America in-vitro colorectal cancer screening tests market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 5.53% during the forecast period of 2024-2032 and is likely to reach a market value of USD 1492.8 million by 2032.
- What are the major factors aiding the Latin America in-vitro colorectal cancer screening tests market demand?
The rising prevalence of colorectal cancer and advancements in screening technology are fuelling the demand for the market.
- What are the major Latin America in-vitro colorectal cancer screening tests market trends?
One of the significant market trends is the increased initiatives and awareness campaigns to promote cancer screening. In October 2023, the Pan American Health Organization (PAHO) and the International Agency for Research on Cancer (IARC) jointly launched the Latin American and the Caribbean Code against Cancer to develop recommendations for cancer prevention in the region.
- What is the market segmentation based on the testing type?
Based on the testing type, the market is segmented into fecal occult blood tests, biomarker tests, CRC DNA screening tests, and flexible sigmoidoscopy, among others.
- What is the market breakup by imaging type?
By imaging type, the market is divided into colonoscopy, proctoscopy, CT scan, ultrasound, MRI, and PET scan.
- What are the major end users of the market?
End users of the market are hospitals, clinics, and diagnostic laboratories.
- What is the market segmentation by countries?
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
- Who are the key players involved in the Latin America in-vitro colorectal cancer screening tests market?
The key players in the market are Beckman Coulter Inc., Abbott, Siemens Healthineers International AG, Quest Diagnostics, Oncocyte Corporation, Merck KGaA, Randox Laboratories Ltd., R-Biopharm AG, Sysmex Corporation, and Medline Industries LP.
Meta description
The Latin America in-vitro colorectal cancer screening tests market is poised for growth, driven by the expansion of the global market, which was valued at USD 920.4 million in 2023 and is projected to grow at a CAGR of 5.53% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America In-vitro Colorectal Cancer Screening Tests Market Overview
3.1 Latin America In-vitro Colorectal Cancer Screening Tests Market Historical Value (2017-2023)
3.2 Latin America In-vitro Colorectal Cancer Screening Tests Market Forecast Value (2024-2032)
4 Latin America In-vitro Colorectal Cancer Screening Tests Market Landscape*
4.1 Latin America In-vitro Colorectal Cancer Screening Tests: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America In-vitro Colorectal Cancer Screening Tests: Product Landscape
4.2.1 Analysis by Test Type
4.2.2 Analysis by Imaging Type
5 Latin America In-vitro Colorectal Cancer Screening Tests Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America In-vitro Colorectal Cancer Screening Tests Market Segmentation (2017-2032)
6.1 Latin America In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Testing Type
6.1.1 Market Overview
6.1.2 Fecal Occult Blood Tests
6.1.3 Biomarker Tests
6.1.4 CRC DNA Screening Tests
6.1.5 Flexible Sigmoidoscopy
6.1.6 Others
6.2 Latin America In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Imaging Type
6.2.1 Market Overview
6.2.2 Colonoscopy
6.2.3 Proctoscopy
6.2.4 CT Scan
6.2.5 Ultrasound
6.2.6 MRI
6.2.7 PET Scan
6.3 Latin America In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Diagnostic Laboratories
6.4 Latin America In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Country
6.4.1 Market Overview
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Others
7 Brazil In-vitro Colorectal Cancer Screening Tests Market (2017-2032)
7.1 Brazil In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Testing Type
7.1.1 Market Overview
7.1.2 Fecal Occult Blood Tests
7.1.3 Biomarker Tests
7.1.4 CRC DNA Screening Tests
7.1.5 Flexible Sigmoidoscopy
7.1.6 Others
7.2 Brazil In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Imaging Type
7.2.1 Market Overview
7.2.2 Colonoscopy
7.2.3 Proctoscopy
7.2.4 CT Scan
7.2.5 Ultrasound
7.2.6 MRI
7.2.7 PET Scan
7.3 Brazil In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Clinics
7.3.4 Diagnostics Laboratories
8 Argentina In-vitro Colorectal Cancer Screening Tests Market (2017-2032)
8.1 Argentina In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Testing Type
8.1.1 Market Overview
8.1.2 Fecal Occult Blood Tests
8.1.3 Biomarker Tests
8.1.4 CRC DNA Screening Tests
8.1.5 Flexible Sigmoidoscopy
8.1.6 Others
8.2 Argentina In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Imaging Type
8.2.1 Market Overview
8.2.2 Colonoscopy
8.2.3 Proctoscopy
8.2.4 CT Scan
8.2.5 Ultrasound
8.2.6 MRI
8.2.7 PET Scan
8.3 Argentina In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Clinics
8.3.4 Diagnostics Laboratories
9 Mexico In-vitro Colorectal Cancer Screening Tests Market (2017-2032)
9.1 Mexico In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Testing Type
9.1.1 Market Overview
9.1.2 Fecal Occult Blood Tests
9.1.3 Biomarker Tests
9.1.4 CRC DNA Screening Tests
9.1.5 Flexible Sigmoidoscopy
9.1.6 Others
9.2 Mexico In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by Imaging Type
9.2.1 Market Overview
9.2.2 Colonoscopy
9.2.3 Proctoscopy
9.2.4 CT Scan
9.2.5 Ultrasound
9.2.6 MRI
9.2.7 PET Scan
9.3 Mexico In-vitro Colorectal Cancer Screening Tests Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Clinics
9.3.4 Diagnostics Laboratories
10 Regulatory Framework
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication Year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by Year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by Departments
12.7 Analysis by Recipient Organization
13 Partnership and Collaborations Analysis
13.1 Analysis by Partnership Instances
13.2 Analysis by Type of Partnership
13.3 Analysis by Leading Players
13.4 Analysis by Geography
14 Supplier Landscape
14.1 Market Share by Top 5 Companies
14.2 Beckman Coulter Inc.
14.2.1 Financial Analysis
14.2.2 Product Portfolio
14.2.3 Demographic Reach and Achievements
14.2.4 Mergers and Acquisitions
14.2.5 Certifications
14.3 Abbott
14.3.1 Financial Analysis
14.3.2 Product Portfolio
14.3.3 Demographic Reach and Achievements
14.3.4 Mergers and Acquisitions
14.3.5 Certifications
14.4 Siemens Healthineers International AG
14.4.1 Financial Analysis
14.4.2 Product Portfolio
14.4.3 Demographic Reach and Achievements
14.4.4 Mergers and Acquisitions
14.4.5 Certifications
14.5 Quest Diagnostics
14.5.1 Financial Analysis
14.5.2 Product Portfolio
14.5.3 Demographic Reach and Achievements
14.5.4 Mergers and Acquisitions
14.5.5 Certifications
14.6 Oncocyte Corporation
14.6.1 Financial Analysis
14.6.2 Product Portfolio
14.6.3 Demographic Reach and Achievements
14.6.4 Mergers and Acquisitions
14.6.5 Certifications
14.7 Merck KGaA
14.7.1 Financial Analysis
14.7.2 Product Portfolio
14.7.3 Demographic Reach and Achievements
14.7.4 Mergers and Acquisitions
14.7.5 Certifications
14.8 Randox Laboratories Ltd.
14.8.1 Financial Analysis
14.8.2 Product Portfolio
14.8.3 Demographic Reach and Achievements
14.8.4 Mergers and Acquisitions
14.8.5 Certifications
14.9 R-Biopharm AG
14.9.1 Financial Analysis
14.9.2 Product Portfolio
14.9.3 Demographic Reach and Achievements
14.9.4 Mergers and Acquisitions
14.9.5 Certifications
14.10 Sysmex Corporation
14.10.1 Financial Analysis
14.10.2 Product Portfolio
14.10.3 Demographic
14.10.4 Mergers and Acquisitions
14.10.5 Certifications
14.11 Medline Industries LP
14.11.1 Financial Analysis
14.11.2 Product Portfolio
14.11.3 Demographic Reach and Achievements
14.11.4 Mergers and Acquisitions
14.11.5 Certifications
15 Latin America In-vitro Colorectal Cancer Screening Tests Market - Distribution Model (Additional Insight)
15.1 Overview
15.2 Potential Distributors
15.3 Key Parameters for Distribution Partner Assessment
16 Key Opinion Leaders (KOL) Insights (Additional Insight)
17 Company Competitiveness Analysis (Additional Insight)
17.1 Very Small Companies
17.2 Small Companies
17.3 Mid-Sized Companies
17.4 Large Companies
17.5 Very Large Companies
18 Payment Methods (Additional Insight)
18.1 Government Funded
18.2 Private Insurance
18.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security